Utrecht University researchers Bas van Ravensteijn and Markus Weingarth have each been awarded an ERC Proof of Concept Grant of €150.000 to further enhance antibiotics and nanomedice
A small group of antibodies in your blood stays the same for years, even after vaccines. These stable antibodies create a unique and personal immune 'fingerprint' that barely changes over time. The discovery helps explain how long-term immunity works.
Apply now for the Public Engagement Academy: a training programme specifically targeted at postdocs and other early-career researchers at the Faculty of Science.
Fundamentally understanding why some antibiotics turn out to be toxic is now a major step closer, thanks to a €1.5 million grant awarded to biochemist Markus Weingarth.
Professor Albert Heck of Utrecht University has delivered the prestigious Mendel Lecture on 17 October 2024. As part of this honour, he received an accompanying Mendel Medal.
The Nobel Prize in Chemistry 2024 was awarded to Demis Hassabis and John Jumper for the development of AlphaFold2 and to David Baker for his work on protein design
A small antibiotic called plectasin uses an innovative Velcro-like mechanism to kill bacteria. Research into how this structure is formed unveils a new approach that could have broad implications for the development of antibiotics to combat antimicrobial resistance.
Patients with rheumatoid arthritis all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers unveiled the complexity of these antibodies using powerful lab tools and challenge current therapeutic approaches.
